TürkiyeResearch and clinical trials
132 patients with liver glycogen storage disease in Adana: type 3 was the most common
Çukurova University reviewed the records of 132 patients with a confirmed genetic diagnosis.
Inborn errors of metabolism
An inherited sugar storage disease. The body cannot fully break down the sugar it has stored. The liver grows large, blood sugar drops during fasting, and the muscles may also be affected.
Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source
Orphanet has a guideline for emergency doctors for this disease (language: French, English). See on Orphanet
This page is translated from the Turkish original.
This disease is followed through the “Inborn errors of metabolism” group.
The body stores sugar as glycogen in the liver and muscles. During fasting, this store is broken down to provide energy. In this disease, an enzyme that does this breakdown is missing. Glycogen cannot be fully broken down and builds up in the tissues. The liver and muscles are affected most.
Symptoms usually begin in the first year of life. The course can be different in each person.
Blood sugar, ketones, liver enzymes, fats and a muscle enzyme are measured in the blood. The diagnosis is confirmed with a genetic test that shows the change in the AGL gene. A liver ultrasound and heart tests are also done.
The main treatment is diet. Not going hungry for long and having frequent, protein-rich meals are important. Slowly digested foods such as uncooked cornstarch may be used at night. Blood sugar and ketones are measured at home. The liver, heart and muscles are checked regularly. A transplant may be considered if the liver is badly damaged. The doctor who follows the disease decides which treatment is suitable.
The disease is passed on through recessive inheritance. The mother and father are usually healthy carriers. For a couple who are both carriers, the chance of having an affected child is 1 in 4 in each pregnancy. In marriages between relatives, the chance of carrying the same gene is higher. Genetic counselling is recommended for the family.
Source: MedlinePlus Genetics: Glycogen storage disease type III · NORD: Glycogen Storage Disease Type III
These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.
Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.
We could not find a patient association specific to this disease.
For all rare diseases: Nadir Hastalıklar Federasyonu
Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.
TürkiyeResearch and clinical trials
Çukurova University reviewed the records of 132 patients with a confirmed genetic diagnosis.
A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.
ClinicalTrials.gov currently lists no active interventional studies for this disease. Last checked: October 7, 2026.
See all studies on ClinicalTrials.gov · Joining clinical trials
EUNew treatments and approvals
In Europe, leriglitazone, taken by mouth, was authorized for cerebral adrenoleukodystrophy.
USANew treatments and approvals
Through the accelerated pathway, the FDA has approved pariglasgene brecaparvovec for glycogen storage disease type Ia.
EuropeResearch and clinical trials
A total of 58 patients from 34 centers in seven European countries were followed.
These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.
Orphanet code: ORPHA:366
No separate ICD-11 code; WHO classifies this disease under: 5C51.3
Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.
This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.